Viewing data from:

CAFFEINE CITRATE

ANDA

CAFFEINE CITRATE | A077304 | EXELA PHARMA SCIENCES LLC

1 strength0 unique patents0 unique exclusivities

API Supply Chain4 active DMFs3 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHCAFFEINE (HYDROUS, ANHYDROUS FORMS)

DMF 50321983

SHANDONG XINHUA PHARMACEUTICAL CO LTDCAFFEINE ANHYDROUS

DMF 130921998

CSPC INNOVATION PHARM CO LTDCaffeine

DMF 210022007

AARTI PHARMALABS LTDCAFFEINE (ANHYDROUS)

DMF 412822025

CULTOR FOOD SCIENCE INCInactiveCAFFEINE

DMF 61821986

AMERICAN BIO SYNTHETICS CORPInactiveCAFFEINE

DMF 90271991

TIANJIN ZHONGAN PHARMACEUTICAL CO LTDInactiveCAFFEINE (ANHYDROUS)

DMF 174862004

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Sep 25, 2006	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

0 patents0 exclusivities▴

SOLUTION;ORAL | Approved: Sep 21, 2006

No patent or exclusivity listings for this strength.